Tabula Rasa HealthCare (TRHC) Misses Q4 EPS by 50c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tabula Rasa Healthcare (TRHC) PT Raised to $19 at Stifel Following Solid 4Q
March 14, 2017 10:24 AM EDTStifel raised its price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $19.00 (from $17.00) while maintaining a Buy rating. Total revenues grew 38% to $27.3m y-y continuing to illustrate the demand for TRHC's innovative technology and services. Net income and EPS on a GAAP basis were ($6m) and... More
Tabula Rasa Healthcare (TRHC) PT Raised to $19 at Piper Jaffray
March 14, 2017 8:48 AM EDTPiper Jaffray raised its price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $19.00 (from $18.00) while maintaining a Overweight rating. 4Q revenue of $27.3M beat the consensus of $25.5M. EPS of $0.10 was just shy of consensus of $0.11.
Analyst Sean Wieland commented, "Tabula Rasa... More
